Our results are of relevance to MM, and also to other inflammation-related malignancies, such as melanoma, breast, GI, prostate, and pancreatic cancers, whose growth and development appear also supported by high levels of HMGB1.7, 8. This evidence concerns the gene HMGB1 and Miyoshi myopathy.